skip to main content

News Archive

Date: 05/11/2013
Written by: Beata Mostafavi. Media Inquiries: 734-764-2220, 8 a.m.-5 p.m. ET or [email protected]
Date: 05/08/2013
Written by: Laurel Thomas Gnagey. Media Inquiries: 734-647-1841, 8 a.m.-5 p.m. ET or [email protected]
Date: 04/16/2013
Written by: Shantell Kirkendoll. Media Inquiries: 734-764-2220 8 a.m.-5 p.m. ET
Date: 04/09/2013
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to University of Michigan Rogel Cancer Center researchers.
Date: 04/03/2013
Large, international trial finds intermittent androgen deprivation is not equivalent to continuous treatment of prostate cancer.
Date: 03/20/2013
Samuel M. Silver, MD, PhD, of the University of Michigan Rogel Cancer Center, has been elected Chairman of the National Comprehensive Cancer Network® (NCCN®) Board of Directors.
Date: 03/12/2013
University of Michigan MOHS clinicians have developed a new technique which delivers good cosmetic result without 2nd procedure.
Date: 03/01/2013
University of Michigan researchers have discovered that inhibiting a signaling pathway in some of the transplanted cells could prevent the most serious potential complications of the procedure, a conflict between the transplanted cells and the recipient's own tissue called graft-versus-host disease.